
Roche obtains special authorisation for bispecific antibody
Roches new developed immunotherapy is based on a bispecific antibody, which targets B-lymphocyte antigen CD20 and the CD3-T-cell receptor at the...

Hot of the press: BIOTECH Insight Newsletter
According to the results of the Biotechnology Company Survey 2022 conducted by BIOCOM AG (Berlin), the turnover of the German biotech sector grew...

New antibody cocktail might fight all corona variants
In experiments, the candidate eliminated virus propagation of all SARS coronaviruses and of MERS,which occured in Saudi Arabia in 2012. If the...

Abliva decides on a SEK200m financing to fund Phase 2/3 study
Swedish Abliva is focussing on mitochondrial medicine, developing therapeutics for primary mitochondrial diseases, orphan indications of high unmet...

French-German Novasep-PharmaZell Group invests EUR7.3M at Mourenx site
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by...

GSK splits off consumer health as Haleon - first stock listing today
Glaxo's consumer healthcare business is currently a joint venture between GSK, which owns 68% and Pfizer (PFE), which has 32%. The demerger...

International Vaccine Institute – IVI – will locate its European office in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified...